生検装置の世界市場 - 市場規模（セグメント別）、シェア、規制、償還、処置、予測（～2033年）

世界のがん発症率の増加は、生検装置市場の主な促進要因の1つです。有病率の増加により、効果的な診断処置に対するニーズが高まり、市場成長に影響を与えています。最小侵襲手術への需要も生検装置市場に寄与しています。技術の進歩や、特に精度の向上、患者の迅速な回復、低侵襲手術といった改良された機能を持つ生検装置は、より安全な処置につながります。診断を促進する政府のプログラムは、診断機器の利用率を向上させると予測されます。

当レポートでは、世界の生検装置市場について調査分析し、各セグメントの市場規模、市場動向、競合情勢、COVID-19の影響などの情報を提供しています。

市場モデルの主な内容は以下の通りです。

上市済みの生検装置と進化する競合情勢

• 主な業界動向の考察
• 生検装置市場のセグメント別の年間収益と市場見通し（2015年～2033年）
• セグメント別の総処置数、ユニット数、平均販売価格、市場金額に関する詳細なデータ

世界、地域、国レベルの市場固有の考察

• 世界の動向を地域別に分類した定性的な市場固有の情報と国別の考察
• 生検装置市場のSWOT分析
• 生検装置市場の競合力学の考察と動向

医療制度の概要を含む真の全体像を把握することで、市場の理解を促進します。また、市場参入セグメントでは、償還政策や規制情勢についての情報を提供し、市場力学をより深く掘り下げることができます。

• 国別の医療制度の概要
• 国別の償還政策
• 国別の医療技術に関する規制情勢

対象企業

• Becton Dickinson and Co
• Danaher Corp
• Hologic Inc
• Cook Group Inc
• Boston Scientific Corp
• Medtronic Plc
• ConMed Corp
• Olympus Corp
• Weigao Group Co Ltd
• Henry Schein Inc
• Coloplast A/S
• Merit Medical Systems Inc
• Integra LifeSciences Holdings Corp
• Teleflex Inc
• Acuderm Inc
• Steris Plc
• その他

List of Tables

Not Applicable

List of Figures

Not Applicable

Abstract

Biopsy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within General Surgery Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Biopsy Devices market for the year 2020 and beyond. A biopsy device is an instrument that aids in the removal of tissue samples from the body. Increasing global cancer incidence is one of the primary drivers of the biopsy devices market. Increasing prevalence results in a growing need for effective diagnostic procedures, which in turn, impacts market growth. Demand for the minimal invasive procedure has also contributed to the biopsy devices market. Advances in technology, especially biopsy devices with improved features such as enhanced accuracy, quicker recovery of patients, and less traumatic procedures, will result in safer procedures. Government programs to promote diagnosis is expected to improve the utilization of diagnostic devices.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Biopsy Devices and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Biopsy Devices market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Biopsy Devices market.
• Competitive dynamics insights and trends provided for Biopsy Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Becton Dickinson and Co, Danaher Corp, Hologic Inc, Cook Group Inc, Boston Scientific Corp, Medtronic Plc, ConMed Corp, Olympus Corp, Weigao Group Co Ltd, Henry Schein Inc, Coloplast A/S, Merit Medical Systems Inc, Integra LifeSciences Holdings Corp, Teleflex Inc, Acuderm Inc, Steris Plc, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Biopsy Devices marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Biopsy Devices market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Biopsy Devices market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Biopsy Devices market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Biopsy Devices market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable